Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer (COG-ANGIO)
Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer : a Pilot Study
Sponsor: Centre Francois Baclesse
Terminated
lack of recruitment
Other terminated trials from Centre Francois Baclesse
Other Metastatic Kidney Cancer trials with similar outcome
A observational or N/A phase clinical study on Metastatic Kidney Cancer, this trial is terminated or withdrawn. The trial is conducted by Centre Francois Baclesse and has accumulated 6 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Oct 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Francois Baclesse
- Hoffmann-La Roche
For direct contact, visit the study record on ClinicalTrials.gov .